Pre-morbid Type 2 Diabetes Mellitus is not a prognostic factor in ALS

di Paganoni, Sabrina, Hyman, Theodore, Shui, Amy, Allred, Peggy, Harms, Matthew, Liu, Jingxia, Maragakis, Nicholas, Schoenfeld, David, Yu, Hong, Atassi, Nazem, Cudkowicz, Merit, Miller, Timothy M.
Pubblicato in Muscle Nerve (2015)

MicroRNA Profiling Reveals Marker of Motor Neuron Disease in ALS Models

di Hoye, Mariah L., Koval, Erica D., Wegener, Amy J., Hyman, Theodore S., Yang, Chengran, O'Brien, David R., Miller, Rebecca L., Cole, Tracy, Schoch, Kathleen M., Shen, Tao, Kunikata, Tomonori, Richard, Jean-Philippe, Gutmann, David H., Maragakis, Nicholas J., Kordasiewicz, Holly B., Dougherty, Joseph D., Miller, Timothy M.
Pubblicato in J Neurosci (2017)

Prospective natural history study of C9orf72 ALS clinical characteristics and biomarkers

di Cammack, Alexander J., Atassi, Nazem, Hyman, Theodore, van den Berg, Leonard H., Harms, Matthew, Baloh, Robert H., Brown, Robert H., van Es, Michael A., Veldink, Jan H., de Vries, Balint S., Rothstein, Jeffrey D., Drain, Caroline, Jockel-Balsarotti, Jennifer, Malcolm, Amber, Boodram, Sonia, Salter, Amber, Wightman, Nicholas, Yu, Hong, Sherman, Alexander V., Esparza, Thomas J., McKenna-Yasek, Diane, Owegi, Margaret A., Douthwright, Catherine, McCampbell, Alexander, Ferguson, Toby, Cruchaga, Carlos, Cudkowicz, Merit, Miller, Timothy M.
Pubblicato in Neurology (2019)